转移性妇科恶性瘤患者的息护理利用趋势和比较
Matthew W Lee1, Intira Sriprasert2, Peter G Phung3
1University of Southern California, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Los Angeles, CA, USA.
概括
与其他癌症相比,患有晚期妇科癌症的患者接受的非治愈干预和息性疼痛管理较少. 这些治疗方法的利用率在妇科恶性瘤中保持不变,与非妇科癌症的显著增加不同.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 妇科瘤学 妇科瘤学
背景情况:
- 先进的妇科恶性瘤在患者护理中提出了独特的挑战.
- 非治愈性干预和缓解性疼痛管理对于改善晚期癌症患者的生活质量至关重要.
- 了解当前的使用模式对于优化护理提供至关重要.
研究的目的:
- 评估在美国患有晚期妇科恶性瘤的患者中使用非治愈性干预和息性疼痛管理.
- 将这些利用率与非妇科恶性瘤的利用率进行比较.
- 识别这些干预措施使用的时间趋势.
主要方法:
- 使用国家癌症数据库 (2004-2020) 进行回顾性队列研究.
- 包括2,098,291名患有第四期恶性瘤的患者 (5例妇科,7例非妇科).
- 分析了非治愈性干预 (全身疗法,手术,放射治疗) 和息性疼痛管理的利用率和趋势.
主要成果:
- 与非妇科恶性瘤相比,妇科恶性瘤的利用率较低 (低于中位数18.3%).
- 随着时间的推移,这些干预措施的利用在妇科癌症中基本保持不变.
- 患有妇科恶性瘤的患者接受非治愈疗法和息性疼痛管理的可能性明显低.
结论:
- 患有晚期妇科恶性瘤的患者显示,不治愈性干预和息性疼痛管理的使用情况没有改变.
- 在妇科和非妇科高级癌症患者之间,在息护理利用方面存在差异.
- 需要进一步调查在晚期妇科恶性瘤的缓解护理的不足利用是合理的.
相关概念视频
01:21Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
01:20Comparing the Survival Analysis of Two or More Groups
122
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
122
01:24Kaplan-Meier Approach
79
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
79
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:25Continuing Care
1.4K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.4K